SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-091854
Filing Date
2024-04-10
Accepted
2024-04-10 16:01:56
Documents
4
Period of Report
2024-05-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A d662042ddef14a.htm DEF 14A 539750
2 GRAPHIC g662042dsp006.jpg GRAPHIC 127085
3 GRAPHIC g662042dsp007.jpg GRAPHIC 126711
4 GRAPHIC g662042g53p02.jpg GRAPHIC 48363
  Complete submission text file 0001193125-24-091854.txt   949244
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39244 | Film No.: 24835734
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)